Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Mahipal

Showing results (71-80 of 179) with videos related to

Pageof 18
Sort By:
Investigational New Drugs|October 10, 2018
Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancerAmit Mahipal, Sri Harsha Tella, Anuhya Kommalapati, et al.
Cancer Immunology, Immunotherapy : CII|May 10, 2019
First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1Amit Mahipal, Samuel Ejadi, Sacha Gnjatic, et al.
Journal of Gastrointestinal Oncology|January 13, 2017
Malignant transformation of biliary adenofibroma: a rare biliary cystic tumorScott M Thompson, Benjamin Zendejas-Mummert, Mindy L Hartgers, et al.
Clinical Nuclear Medicine|June 9, 2015
PET/CT Fusion Scan Prevents Futile Laparotomy in Early Stage Pancreatic CancerRichard Kim, Gopi Prithviraj, Nishi Kothari, et al.
JCO Precision Oncology|August 18, 2023
Outcome of Patients With Early-Stage Mismatch Repair Deficient Colorectal Cancer Receiving Neoadjuvant Immunotherapy: A Systematic ReviewSakti Chakrabarti, Udhayvir Singh Grewal, Kruti Bhagirath Vora, et al.
Cancer Control : Journal of the Moffitt Cancer Center|June 13, 2015
Effect of Age on Clinical Outcomes in Phase 1 Trial ParticipantsAmit Mahipal, Aaron C Denson, Benjamin Djulbegovic, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 4, 2020
Neutrophil to lymphocyte ratio as a prognostic marker in metastatic gallbladder cancerMohamed Mady, Kritika Prasai, Sri H Tella, et al.
Investigational New Drugs|March 1, 2021
Phase IB study of sorafenib and evofosfamide in patients with advanced hepatocellular and renal cell carcinomas (NCCTG N1135, Alliance)Nguyen H Tran, Nathan R Foster, Amit Mahipal, et al.
Cancer|September 15, 2005
Axillary disease recurrence after sentinel lymph node dissection for breast carcinomaKaren K Swenson, Amit Mahipal, Mary J Nissen, et al.
Cancers|February 24, 2024
Projected Incidence of Hepatobiliary Cancers and Trends Based on Age, Race, and Gender in the United StatesMichael H Storandt, Sri Harsha Tella, Mikolaj A Wieczorek, et al.
Pageof 18

Showing results (71-80 of 179) with videos related to

Sort By:
Pageof 18
Investigational New Drugs|October 10, 2018
Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancerAmit Mahipal, Sri Harsha Tella, Anuhya Kommalapati, et al.
Cancer Immunology, Immunotherapy : CII|May 10, 2019
First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1Amit Mahipal, Samuel Ejadi, Sacha Gnjatic, et al.
Journal of Gastrointestinal Oncology|January 13, 2017
Malignant transformation of biliary adenofibroma: a rare biliary cystic tumorScott M Thompson, Benjamin Zendejas-Mummert, Mindy L Hartgers, et al.
Clinical Nuclear Medicine|June 9, 2015
PET/CT Fusion Scan Prevents Futile Laparotomy in Early Stage Pancreatic CancerRichard Kim, Gopi Prithviraj, Nishi Kothari, et al.
JCO Precision Oncology|August 18, 2023
Outcome of Patients With Early-Stage Mismatch Repair Deficient Colorectal Cancer Receiving Neoadjuvant Immunotherapy: A Systematic ReviewSakti Chakrabarti, Udhayvir Singh Grewal, Kruti Bhagirath Vora, et al.
Cancer Control : Journal of the Moffitt Cancer Center|June 13, 2015
Effect of Age on Clinical Outcomes in Phase 1 Trial ParticipantsAmit Mahipal, Aaron C Denson, Benjamin Djulbegovic, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 4, 2020
Neutrophil to lymphocyte ratio as a prognostic marker in metastatic gallbladder cancerMohamed Mady, Kritika Prasai, Sri H Tella, et al.
Investigational New Drugs|March 1, 2021
Phase IB study of sorafenib and evofosfamide in patients with advanced hepatocellular and renal cell carcinomas (NCCTG N1135, Alliance)Nguyen H Tran, Nathan R Foster, Amit Mahipal, et al.
Cancer|September 15, 2005
Axillary disease recurrence after sentinel lymph node dissection for breast carcinomaKaren K Swenson, Amit Mahipal, Mary J Nissen, et al.
Cancers|February 24, 2024
Projected Incidence of Hepatobiliary Cancers and Trends Based on Age, Race, and Gender in the United StatesMichael H Storandt, Sri Harsha Tella, Mikolaj A Wieczorek, et al.
Pageof 18